Cargando…

A randomized, controlled field study to assess the efficacy and safety of lotilaner flavored chewable tablets (Credelio™ CAT) in eliminating fleas in client-owned cats in the USA

BACKGROUND: Studies show that the novel isoxazoline, lotilaner (Credelio™ CAT; Elanco Animal Health), which is administered orally to cats, provides rapid and sustained flea kill for least 1 month following administration with a wide safety margin. A clinical trial was undertaken to confirm its effi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chappell, Kimberly, Paarlberg, Tandy, Seewald, Wolfgang, Karadzovska, Daniela, Nanchen, Steve
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7923547/ https://www.ncbi.nlm.nih.gov/pubmed/33648556 http://dx.doi.org/10.1186/s13071-021-04617-5

Ejemplares similares

A randomized, controlled field study to assess the efficacy and safety of lotilaner flavored chewable tablets (Credelio™) in eliminating fleas in client-owned dogs in the USA
por: Karadzovska, Daniela, et al.
Publicado: (2017)

Efficacy of lotilaner (Credelio™) against experimentally induced infestations of the adult cat flea, Ctenocephalides felis, and flea eggs following oral administration to cats
por: Paarlberg, Tandy, et al.
Publicado: (2021)

A randomized, controlled field study to assess the efficacy and safety of lotilaner (Credelio™) in controlling fleas in client-owned cats in Europe
por: Cavalleri, Daniela, et al.
Publicado: (2018)

A randomized, controlled field study to assess the efficacy and safety of lotilaner (Credelio™) in controlling ticks in client-owned cats in Europe
por: Cavalleri, Daniela, et al.
Publicado: (2018)

Safety of lotilaner flavoured chewable tablets (Credelio(TM)) after oral administration in cats
por: Kuntz, Emmanuelle A., et al.
Publicado: (2018)

A randomised, blinded, controlled field study to assess the efficacy and safety of lotilaner tablets (Credelio™) in controlling fleas in client-owned dogs in European countries
por: Cavalleri, Daniela, et al.
Publicado: (2017)

Assessment of the onset of lotilaner (Credelio™) speed of kill of fleas on dogs
por: Cavalleri, Daniela, et al.
Publicado: (2017)

Efficacy of lotilaner (Credelio™) against the adult cat flea, Ctenocephalides felis and flea eggs following oral administration to dogs
por: Young, Lisa, et al.
Publicado: (2020)

Laboratory evaluation of the efficacy and speed of kill of lotilaner (Credelio™) against Ctenocephalides felis on cats
por: Cavalleri, Daniela, et al.
Publicado: (2018)

A randomized, controlled study to assess the efficacy and safety of lotilaner (Credelio™) in controlling ticks in client-owned dogs in Europe
por: Cavalleri, Daniela, et al.
Publicado: (2017)

Assessment of the speed of flea kill of lotilaner (Credelio™) throughout the month following oral administration to dogs
por: Cavalleri, Daniela, et al.
Publicado: (2017)

Laboratory evaluation of the efficacy and speed of kill of lotilaner (Credelio(TM)) against Ixodes ricinus ticks on cats
por: Cavalleri, Daniela, et al.
Publicado: (2018)

Safety evaluation of lotilaner in dogs after oral administration as flavoured chewable tablets (Credelio™)
por: Kuntz, Emmanuelle A., et al.
Publicado: (2017)

Laboratory evaluation of the speed of kill of lotilaner (Credelio™) against Ixodes ricinus ticks on dogs
por: Murphy, Martin, et al.
Publicado: (2017)

Laboratory evaluation of the efficacy of lotilaner (Credelio™) against Haemaphysalis longicornis infestations of dogs
por: Otaki, Hiroshi, et al.
Publicado: (2018)

Laboratory evaluations of the immediate and sustained efficacy of lotilaner (Credelio™) against four common species of ticks affecting dogs in North America
por: Murphy, Martin, et al.
Publicado: (2017)

Two randomized, controlled studies to assess the efficacy and safety of lotilaner (Credelio™) in preventing Dermacentor reticulatus transmission of Babesia canis to dogs
por: Cavalleri, Daniela, et al.
Publicado: (2017)

Laboratory evaluations of the immediate and sustained effectiveness of lotilaner (Credelio™) against three common species of ticks affecting dogs in Europe
por: Cavalleri, Daniela, et al.
Publicado: (2017)

Effectiveness of Credelio(®) Plus, a novel chewable tablet containing milbemycin oxime and lotilaner for the treatment of larval and immature adult stages of Toxocara canis in experimentally infected dogs
por: Young, Lisa M., et al.
Publicado: (2021)

Laboratory evaluations of the 3-month efficacy of oral lotilaner (Credelio™) against experimental infestations of dogs with the Australian paralysis tick, Ixodes holocyclus
por: Baker, Kim, et al.
Publicado: (2018)

Lotilaner - a novel formulation for cats provides systemic tick and flea control
por: Wright, Ian
Publicado: (2018)

In-home assessment of flea control and dermatologic lesions in dogs provided by lotilaner (Credelio(®)) and spinosad (Comfortis(®)) in west central Florida
por: Dryden, Michael W., et al.
Publicado: (2019)

Laboratory evaluation of the efficacy of lotilaner (Credelio™) against Amblyomma cajennense (sensu lato) infestations of dogs
por: Lasmar, Pedro Veloso Facury, et al.
Publicado: (2018)

Pharmacokinetics of lotilaner following a single oral or intravenous administration in cats
por: Toutain, Céline E., et al.
Publicado: (2018)

Randomized Placebo‐Controlled Clinical Trial of a Chewable Formulation of Amlodipine for the Treatment of Hypertension in Client‐Owned Cats
por: Huhtinen, M., et al.
Publicado: (2015)

Safety and efficacy of a novel oral chewable combination tablet containing sarolaner, moxidectin and pyrantel (Simparica Trio™) against natural flea infestations in client-owned dogs in the USA
por: Kryda, Kristina, et al.
Publicado: (2020)

Effectiveness and residual speed of flea kill of a novel spot on formulation of spinetoram (Cheristin(®)) for cats
por: Paarlberg, Tandy, et al.
Publicado: (2017)

Acceptance of oclacitinib maleate (Apoquel®) chewable tablets in client-owned dogs with allergic and atopic dermatitis
por: Visser, Marike, et al.
Publicado: (2022)

Field study to investigate the effectiveness and safety of a novel orally administered combination drug product containing milbemycin oxime and lotilaner (Credelio(®) Plus) for the prevention of heartworm disease (Dirofilaria immitis) in client-owned dogs in the USA
por: Young, Lisa M., et al.
Publicado: (2021)

Bartonella Infections in Cats and Cat Fleas in Lithuania
por: Razgūnaitė, Miglė, et al.
Publicado: (2021)

Early onset of pre-lethal effects of lotilaner (Credelio(®)) on Amblyomma americanum ticks on experimentally infested dogs
por: Wenger, Martha J., et al.
Publicado: (2021)

Efficacy and safety of oral robenacoxib (tablet) for the treatment of pain associated with soft tissue surgery in client-owned dogs
por: Friton, Gabriele, et al.
Publicado: (2017)

Efficacy of indoxacarb applied to cats against the adult cat flea, Ctenocephalides felis, flea eggs and adult flea emergence
por: Dryden, Michael W, et al.
Publicado: (2013)

Lotilaner - a novel systemic tick and flea control product for dogs
por: Little, Susan E.
Publicado: (2017)

Recent Advancements in the Control of Cat Fleas
por: Rust, Michael K.
Publicado: (2020)

The intravenous and oral pharmacokinetics of lotilaner in dogs
por: Toutain, Céline E., et al.
Publicado: (2017)

Efficacy of Spinosad Tablets Administered to a Colony of 15 Indoor Cats Naturally Infested with Fleas
por: Cadiergues, Marie-Christine, et al.
Publicado: (2014)

Acute pharmacodynamic effects of pimobendan in client-owned cats with subclinical hypertrophic cardiomyopathy
por: Oldach, Maureen S., et al.
Publicado: (2021)

Prevalence of hemoplasmas and Bartonella species in client-owned cats in Beijing and Shanghai, China
por: ZHANG, Yingxin, et al.
Publicado: (2021)

Seroprevalence of SARS-CoV-2 in Client-Owned Cats from Portugal
por: Oliveira, Andreia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ih267mdnar6iu1rt46fk9l24g1